Both in Lab Analytical Instruments
10x Genomics vs Bio-Rad Laboratories
Over the past year TXG returned +411.8% and BIO returned +19.5%; their daily moves had a correlation of 0.41.
TXG +411.8% BIO +19.5%Growth of $1, one year, split-adjusted
| Metric | TXG | BIO |
|---|---|---|
| Price | $70.11 | $372.18 |
| Market cap | $9.13B | $9.95B |
| Today | −14.03% | −3.18% |
| 1 month | −21.0% | +4.7% |
| 6 months | +212.6% | +45.1% |
| Year to date | +329.9% | +22.8% |
| 1 year | +443.5% | +16.5% |
| Revenue growth (YoY) | −12.6% | −0.1% |
| Gross margin | 74.5% | 53.1% |
| Net margin | −11.9% | 57.1% |
| P/E (TTM) | — | 44.7× |
| Price / sales | 14.8× | 3.8× |
| Net cash | $552.0M | $414.8M |
| Dividend yield | — | — |
| Volatility (60d) | 87.8% | 27.7% |
| Short % of float | 10.9% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).